114 related articles for article (PubMed ID: 1678082)
1. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans.
Baggio B; Gambaro G; Marchini F; Marzaro G; Williams HE; Borsatti A
Lancet; 1991 Aug; 338(8764):403-5. PubMed ID: 1678082
[TBL] [Abstract][Full Text] [Related]
2. Effects of the oral administration of glycosaminoglycans on cellular abnormalities associated with idiopathic calcium oxalate nephrolithiasis.
Baggio B; Gambaro G; Marzaro G; Marchini F; Borsatti A; Crepaldi G
Eur J Clin Pharmacol; 1991; 40(3):237-40. PubMed ID: 2060558
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan content, oxalate self-exchange and protein phosphorylation in erythrocytes of patients with 'idiopathic' calcium oxalate nephrolithiasis.
Baggio B; Marzaro G; Gambaro G; Marchini F; Williams HE; Borsatti A
Clin Sci (Lond); 1990 Aug; 79(2):113-6. PubMed ID: 2167799
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic calcium oxalate nephrolithiasis: a cellular disease.
Gambaro G; Baggio B
Scanning Microsc; 1992 Mar; 6(1):247-54. PubMed ID: 1626244
[TBL] [Abstract][Full Text] [Related]
5. An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics.
Baggio B; Gambaro G; Marchini F; Cicerello E; Tenconi R; Clementi M; Borsatti A
N Engl J Med; 1986 Mar; 314(10):599-604. PubMed ID: 3945245
[TBL] [Abstract][Full Text] [Related]
6. [Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis].
Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
Nephrologie; 1984; 5(4):173-4. PubMed ID: 6527719
[TBL] [Abstract][Full Text] [Related]
7. Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalate nephrolithiasis.
Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
Lancet; 1984 Jul; 2(8393):12-3. PubMed ID: 6145933
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
Gambaro G; Petrarulo M; Nardelotto A; Marangella M; Baggio B
Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
[TBL] [Abstract][Full Text] [Related]
9. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
10. Calcium oxalate nephrolithiasis: defective oxalate transport.
Borsatti A
Kidney Int; 1991 Jun; 39(6):1283-98. PubMed ID: 1895680
[No Abstract] [Full Text] [Related]
11. Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: clinical implications in calcium oxalate nephrolithiasis.
Baggio B; Priante G; Brunati AM; Clari G; Bordin L
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S381-4. PubMed ID: 10541268
[TBL] [Abstract][Full Text] [Related]
12. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
Baggio B; Gambaro G; Zambon S; Marchini F; Bassi A; Bordin L; Clari G; Manzato E
J Am Soc Nephrol; 1996 Apr; 7(4):613-20. PubMed ID: 8724896
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a link between erythrocyte band 3 phosphorylation and anion transport in patients with 'idiopathic' calcium oxalate nephrolithiasis.
Baggio B; Bordin L; Gambaro G; Piccoli A; Marzaro G; Clari G
Miner Electrolyte Metab; 1993; 19(1):17-20. PubMed ID: 8393959
[TBL] [Abstract][Full Text] [Related]
14. Pyridoxine therapy in patients with renal calcium oxalate calculi.
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
[TBL] [Abstract][Full Text] [Related]
15. Abnormal urate transport in erythrocytes of patients with idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria.
Gambaro G; Vincenti M; Marchini F; D'Angelo A; Baggio B
Clin Sci (Lond); 1993 Jul; 85(1):41-4. PubMed ID: 8149692
[TBL] [Abstract][Full Text] [Related]
16. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
Gambaro G; Marchini F; Piccoli A; Nassuato MA; Bilora F; Baggio B
J Am Soc Nephrol; 1996 Apr; 7(4):608-12. PubMed ID: 8724895
[TBL] [Abstract][Full Text] [Related]
17. Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.
Holmes RP; Knight J; Assimos DG
Urolithiasis; 2016 Feb; 44(1):27-32. PubMed ID: 26614109
[TBL] [Abstract][Full Text] [Related]
18. Oxalate metabolism and renal calculi.
Menon M; Mahle CJ
J Urol; 1982 Jan; 127(1):148-51. PubMed ID: 7035692
[TBL] [Abstract][Full Text] [Related]
19. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
Müller G; Schütte W; Berg W; Möller T
Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
[TBL] [Abstract][Full Text] [Related]
20. Effect of diclofenac-Na on 24-hour urinary excretion of creatinine, calcium, uric acid and glycosaminoglycans in adult patients with recurrent calcium oxalate nephrolithiasis.
Hemal AK; Sidhu H; Thind SK; Nath R; Vaidyanathan S
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):44-6. PubMed ID: 2744906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
